Top Suppliers:I want be here
Related CAS#:
148849-67-6 5788-94-3
6105-16-4 1086026-38-1
1246638-08-3 1217809-61-4
85175-52-6 2733718-12-0
1346600-74-5 1406-14-0
1158522-08-7 940364-43-2
134104-43-1 2228289-39-0
1502049-72-0 2028907-78-8
131615-57-1 2171770-49-1
2172559-48-5 2580098-61-7

148849-67-6

148849-67-6 structure
148849-67-6 structure
Name ivabradine hydrochloride
Synonyms Ivabradine hydrochloride
AMG 998
Coralan
Procoralan
Corlentor
3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one,hydrochloride
ivabradine monohydrochloride
2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-, monohydrochloride
Ivabradine hcl
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1)
MFCD00929899
3-{3-[{[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino]propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride (1:1)
UNII-TP19837BZK
Corlanor
Description Ivabradine (hydrochloride) is a new If inhibitor with IC50 of 2.9 μM, and used as a pure heart rate lowering agent.
Related Catalog
In Vivo Ivabradine treatment (10 mg/kg/d) induces long-term HRR, and that improves diastolic LV function probably involving attenuated hypoxia, reduced remodeling, and/or preserved nitric oxide bioavailability, resulting from processes triggered early after HRR initiation: angiogenesis and/or preservation of endothelial nitric oxide synthase expression[1]. Ivabradine leads to a sustained 15-20% heart rate reduction, but has no effect on blood pressure. While ivabradine has no effect on endothelial function and vascular reactive oxygen species production in angiotensin II-treated rats, it improves both parameters in ApoE knockout mice. Ivabradine treatment leads to an attenuation of angiotensin II signaling and increased the expression of telomere-stabilizing proteins in ApoE knockout mice, which may explain its beneficial effects on the vasculature. The absence of these protective ivabradine effects in angiotensin II-infused rats may relate to the treatment duration or the presence of arterial hypertension[2].
References

[1]. Fang, Y., et al. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia. J Cardiovasc Pharmacol, 2012. 59(3): p. 260-7.

[2]. Kroller-Schon, S., et al. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res Cardiol, 2011. 106(6): p. 1147-58.
Boiling Point 626.9ºC at 760mmHg
Melting Point 193-196?C
Molecular Formula C27H37ClN2O5
Molecular Weight 505.046
Flash Point 332.9ºC
Exact Mass 504.239105
PSA 60.47000
LogP 4.04990
Vapour Pressure 1.24E-15mmHg at 25°C
Storage condition -20°C Freezer
Symbol GHS09
GHS09
Signal Word Warning
Hazard Statements H400
Precautionary Statements P273
Hazard Codes N
Risk Phrases 50/53
Safety Phrases 60-61
RIDADR UN 3077 9 / PGIII

Chemsrc provides CAS#:148849-67-6 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 148849-67-6 | Chemsrc address: https://www.chemsrc.com/en/baike/1020741.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved